IFN-DCs have subsequently been reported to easily recognize apoptotic tumor cells and to efficiently cross-present tumor-derived antigens to CD8+ T cells, thus leading to an increased cross-priming also against tumor-associated antigens [40]. Here, CD8A is linked to neoplasm.